Metathesis reactions for the synthesis of ring-fused carbazoles

Journal of Organic Chemistry

Volumn 70, Issue 25, 2005, Pages 10474-10481

  Pelly, Stephen C ^a   Parkinson, Christopher J ^b   Van Otterlo, Willem A L ^a   De Koning, Charles B ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b DSI CSIR Nanotechnology Innovation Centre   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

REACTION KINETICS; SULFUR; SYNTHESIS (CHEMICAL);

ELECTROCYCLIZATION; METATHESIS REACTION; RING-FUSED CARBAZOLES; SULFUR ANALOG;

NITROGEN COMPOUNDS;

CARBAZOLE DERIVATIVE; FUROSTIFOLINE; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; INDOLO[2,3 A]CARBAZOLE DERIVATIVE; ISOGRANULATIMIDE; NATURAL PRODUCT; REBECCAMYCIN; TERT BUTYL 2 (2 ISOPROPENYL 3 FURYL) 3 VINYL 1H INDOLE 1 CARBOXYLIC ACID; TERT BUTYL 2A METHYL 1,2,2A,10C TETRAHYDRO 6H CYCLOBUTA[C]FURO[3,2 A]CARBAZOLE 6 CARBOXYLIC ACID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BILE DUCT CANCER; CHEMICAL REACTION; CHEMICAL STRUCTURE; CYCLIZATION; DRUG DNA BINDING; DRUG ISOLATION; DRUG SYNTHESIS; HUMAN; LEUKEMIA; LIVER CANCER; RING CLOSING METATHESIS;

CARBAZOLES; CYCLIZATION; INDOLES; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 28744447770     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo051826s     Document Type: Article

References (40)

1. Knölker H.-J.; Reddy, K. R. Chem. Rev. 2002, 702, 4303 and references therein.
2. Prudhomme, M. Curr. Med. Chem. 2000, 7, 1189.
3. Moreau, P.; Anizon, F.; Sancelme, M.; Prudhomme, M.; Bailly, C.; Carrasco, C.; Ollier, M.; Sevère, D.; Riou, J.-F.; Fabbro, D.; Meyer, T.; Aubertin, A.-M. J. Med. Chem. 1998, 41, 1631.
4. Moreau, P.; Anizon, F.; Sancelme, M.; Prudhomme, M.; Sevère, D.; Riou, J.-F.; Goossens, J.-F.; Hénichart, J.-P.; Bailly, C.; Labourier, E.; Tazzi, J.; Fabbro, D.; Meyer, T.; Aubertin, A. M. J. Med. Chem. 1999, 42, 1816.
5. Bailly, C.; Riou, J.-F.; Colson, P.; Houssier, C.; Rodrigues-Periera, E.; Prudhomme, M. Biochemistry 1997, 36, 3917.
6. Rodrigues Pereira, E.; Belin, L.; Sancelme, M.; Prudhomme, M.; Ollier, M.; Rapp, M.; Sevère, D.; Riou, J.-F.; Fabbro, D.; Meyer, T. J. Med. Chem. 1996, 39, 4471.
7. Long, B. H.; Rose, W. C.; Vyas, D. M.; Matson, J. A.; Forenza, S. Curr. Med. Chem.: Anti-Cancer Agents 2002, 2, 255.
8. Long, B. H.; Balasubramanian, B. N. Expert Opin. Ther. Pat. 2000, 10, 635.
9. See ClinicalTrials.gov Web site, http://www.clinicaltrials.gov/ct/gui/ show/NCT00005997 or http://www.clinicaltrials.gov/ct/gui/show/NCT00087204, accessed August 2005.
10. For a review, see: Fröhner, W.; Krahl, M. P.; Reddy, K. R.; Knölker, H.-J. Heterocyles 2004, 63, 2393.
11. (a) Knölker H.-J.; Fröhner, W. Tetrahedron Lett. 1996, 37, 9183.
12. (b) Knölker H.-J.; Fröhner, W. Synthesis 2000, 2131.
13. (a) Hagiwara, H.; Choshi, T.; Fujimoto, H.; Sugino, E.; Hibino, S. Chem. Pharm. Bull. 1998, 46, 1948.
14. (b) Hagiwara, H.; Choshi, T.; Nobuhiro, J.; Hibino, S. Chem. Pharm. Bull. 2001, 49, 881.
15. Soós, T.; Timári, G.; Hajós, G. Tetrahedron Lett. 1999, 40, 8607.
16. Beccalli, E.; Clerici, F.; Marchesini, A. Tetrahedron 1998, 54, 11675.
17. Yasuhara, A.; Suzuki, N.; Sakamoto, T. Chem. Pharm. Bull. 2002, 50, 143.
18. Bergman, H.; Williams, D. S.; Atilla, G. E.; Carroll P. J.; Meggers, E. J. Am. Chem. Soc. 2004, 126, 13594.
19. Routier, S.; Peixoto, P.; Mérour, J.-Y.; Coudert, G.; Dias, N.; Bailly, C.; Pierré, A.; Léonce S.; Caignard, D.-H. J. Med. Chem. 2005, 48, 1401.
20. (a) de Koning, C. B.; Michael, J. P.; Rousseau, A. L. J. Chem. Soc., Perkin Trans. 1 2000, 1705.
21. (b) de Koning, C. B.; Michael, J. P.; Nhlapo, J. M.; Pathak, R.; van Otterlo, W. A. L. Synlett 2003, 705.
22. For reviews on metathesis, see: (a) Schmalz, H.-G. Angew. Chem., Int. Ed. Engl. 1995, 34, 1833.
23. (b) Schuster, M.; Blechert, S. Angew. Chem., Int. Ed. Engl. 1997, 36, 2036.
24. (c) Grubbs, R.; Chang, S. Tetrahedron 1998, 54, 4413.
25. (d) Fürstner, A. Angew. Chem., Int. Ed. 2000, 39, 3012.
26. (e) Jørgensen, M.; Hadwiger, P.; Madsen, R.; Stütz, A. E.; Wrodnigg, T. M. Curr. Org. Chem. 2000, 4, 565.
27. (f) Hoveyda, A. H.; Schrock R. R. Chem.-Eur. J. 2001, 7, 945.
28. (g) Trnka, T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34, 18.
29. (h) McReynolds, M. D.; Dougherty, J. M.; Hanson, P. R. Chem. Rev. 2004, 104, 2239.
30. (i) Deiters, A.; Martin, S. F. Chem. Rev. 2004, 104, 2199.
31. (a) For the synthesis of phenanthrenes using ring-closing metathesis to form an aromatic ring, see: (i) Iuliano, A.; Piccioli, P.; Fabbri, D. Org. Lett. 2004, 6, 3711
32. and (ii) Walker, E. R.; Leung, S. Y.; Barrett, A. G. M. Tetrahedron Lett. 2005, 46, 6537.
33. (b) Phenols, naphthols, and naphthalenes, respectively, have been made using ring-closing metathesis: (i) Yoshida, K.; Imamoto, T. J. Am. Chem. Soc. 2005, 127, 10470.
34. (ii) van Otterlo, W. A. L.; Ngidi, E. M.; Coyanis, E. M.; de Koning, C. B. Tetrahedron Lett. 2003, 44, 311.
35. (iii) Huang, K,-S.; Wang, E.-C. Tetrahedron Lett. 2001, 42, 6155.
36. (c) For an example of ring-closing metathesis followed by oxidative aromatization to form a benzene ring, see: Kotha, S.; Mandal, K. Tetrahedron Lett. 2004, 45, 2585.
37. (d) Some researchers have used the same initial retrosynthetic approach as us by using the Suzuki-Miyaura coupling reaction at an early stage to make the bis-indole 2 and 2′ linkage. See: Cai, C.; Snieckus, V. Org. Lett. 2004, 6, 2293.
38. Bergman, J.; Koch, E.; Pelcman, B. Tetrahedron 1995, 51, 5631.
39. (a) Koyanagi, J.; Yamamoto, K.; Nakayama, K.; Tanaka, A. J. Heterocycl. Chem. 1995, 32, 1289.
40. (b) Lutz, G.-B.; Otto, H.-H. Arch. Pharm. 1991, 324, 563